A stem cell therapy developed by the biotech company Nature Cell and the Biostar Stem Cell Research Institute, both based in South…
Articles by Patricia Inacio, PhD
A simple test of amyloid-beta protein levels in a person’s blood may offer a way to diagnose Alzheimer’s disease up…
An injection of IONIS-MAPTRx resulted in a 70 percent decrease in tau protein produced in the brains of non-human primates,…
Long-term exposure to caffeine worsens Alzheimer’s disease symptoms, a new mouse study shows. The study “Long-term Treatment with Low-Dose…
Spanish regulators have signed off on Oryzon Genomics’ plan to conduct a Phase 2 clinical trial of its Alzheimer’s therapy ORY-2001. The…
The brain works in a coordinated matter, like a tuned orchestra, scientists say. If a single instrument is out of…
The harmful tau protein associated with Alzheimer’s appears in one place in the brain, then spreads, rather than showing up…
Three Phase 3 clinical studies have failed to reproduce previously reported benefits of adding investigational idalopirdine to a background therapy…
The gut microbiome is increasingly seen as a key player in serious and chronic neurodegenerative diseases like Alzheimer’s and Parkinson’s…
Salk Institute researchers have discovered how a therapy they are developing alleviates the symptoms of …